Natali A, Boldrini B, Baldi S, Rossi M, Landi P, Severi S, Solini A, Ferrannini E
Department of Clinical and Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy.
Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):681-8. doi: 10.1016/j.numecd.2013.12.005. Epub 2013 Dec 24.
BACKGROUND & AIMS: The bases of the link between reduced glomerular filtration rate (GFR) and coronary artery disease (CAD) are complex and to some extent still unclear. We performed this observational, single referral center, cohort study to evaluate whether mild to moderate GFR reduction is associated with more severe CAD and/or with a worse cardiac prognosis independently of proteinuria, diabetes and traditional risk factors.
In 1752 consecutive non-diabetic patients without proteinuria or moderate/severe kidney disease undergoing a clinically driven coronary angiography, coronary arteries lesions, myocardial function and hypertrophy and 10-yrs incidence of cardiac events and death were evaluated in relation to classes of estimated GFR defined according the lowest eGFR value (105+, 90+, 75+, 60+, 45+). A reduced eGFR was independently associated with hypertension, myocardial hypertrophy and stress induced ischemia, while the excess coronary lesions and the worse myocardial systolic function were both largely explained by age and cardiovascular risk factors. When compared to subjects 75+, both the risk of cardiac death (1.67[1.10-2.57] and 3.06[1.85-5.10]) and non-fatal myocardial infarction (2.58[1.12-6.49] and 2.73[1.31-6.41]) adjusted for age and comorbidities were higher in eGFR 60+ and 45+ patients.
A mild-moderate reduction of eGFR is closely associated to higher rates of stress-induced ischemia, myocardial hypertrophy and higher risk of fatal and non-fatal cardiac events. The associations of reduced eGFR with coronary atherosclerosis and myocardial systolic dysfunction are both largely explained by age and traditional risk factors.
肾小球滤过率(GFR)降低与冠状动脉疾病(CAD)之间联系的基础复杂,在一定程度上仍不清楚。我们进行了这项观察性、单转诊中心队列研究,以评估轻度至中度GFR降低是否与更严重的CAD和/或更差的心脏预后相关,且独立于蛋白尿、糖尿病和传统危险因素。
在1752例连续的无蛋白尿或中度/重度肾脏疾病的非糖尿病患者中,这些患者接受了临床驱动的冠状动脉造影,评估了冠状动脉病变、心肌功能和肥厚以及心脏事件和死亡的10年发生率,这些与根据最低估算肾小球滤过率(eGFR)值定义的估算GFR类别(105+、90+、75+、60+、45+)相关。eGFR降低与高血压、心肌肥厚和应激诱导的缺血独立相关,而冠状动脉病变过多和心肌收缩功能较差在很大程度上由年龄和心血管危险因素解释。与75岁以上的受试者相比,经年龄和合并症调整后,eGFR 60+和45+的患者心脏死亡风险(分别为1.67[1.10 - 2.57]和3.06[1.85 - 5.10])和非致命性心肌梗死风险(分别为2.58[1.12 - 6.49]和2.73[1.31 - 6.41])更高。
eGFR轻度至中度降低与应激诱导的缺血发生率较高、心肌肥厚以及致命和非致命心脏事件的较高风险密切相关。eGFR降低与冠状动脉粥样硬化和心肌收缩功能障碍之间的关联在很大程度上由年龄和传统危险因素解释。